Baker Avenue Asset Management’s MacroGenics MGNX Stock Holding History

Baker Avenue Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,000	Closed	-$58K	–	243
2020 Q1	$58K	Buy	+10,000	New	+$90.8K	0.01%	194
2019 Q4	–	Sell	-10,000	Closed	-$127K	–	264
2019 Q3	$127K	Hold	10,000	–	–	0.01%	236
2019 Q2	$169K	Hold	10,000	–	–	0.01%	232
2019 Q1	$179K	Buy	+10,000	New	+$173K	0.01%	237

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Baker Avenue Asset Management's MGNX Position: Q2 2020 in Review

Baker Avenue Asset Management sold out of MacroGenics (MGNX) in Q2 2020, closing a stake of 10,000 shares — an estimated $58K sold.

Baker Avenue Asset Management first reported a position in MGNX in Q1 2019 and held it in 4 quarters. The position peaked at $179K in Q1 2019. 137 funds tracked by Wall St. Rank hold MGNX as of Q2 2020.

Baker Avenue Asset Management reported no remaining MacroGenics position as of Q2 2020 after selling out during the quarter.
Baker Avenue Asset Management sold 10,000 MacroGenics shares in Q2 2020, an estimated $58K.
Baker Avenue Asset Management first reported a position in MacroGenics in Q1 2019 and held it in 4 quarters.
Baker Avenue Asset Management's MacroGenics position peaked at $179K in Q1 2019.
137 funds tracked by Wall St. Rank held MacroGenics as of Q2 2020.

Based on Baker Avenue Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.